Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Cash from Operations (2020 - 2025)

Vivos Therapeutics has reported Cash from Operations over the past 6 years, most recently at 3763000.0 for Q4 2025.

  • Quarterly Cash from Operations fell 29.76% to 3763000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 15263000.0 through Dec 2025, down 20.18% year-over-year, with the annual reading at 15263000.0 for FY2025, 20.18% down from the prior year.
  • Cash from Operations was 3763000.0 for Q4 2025 at Vivos Therapeutics, up from 4200000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 2500000.0 in Q1 2024 and troughed at 6100000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 3709000.0 (2021), against an average of 3759900.0.
  • Year-over-year, Cash from Operations crashed 792.63% in 2021 and then soared 52.51% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 4122000.0 in 2021, then increased by 27.22% to 3000000.0 in 2022, then increased by 10.0% to 2700000.0 in 2023, then dropped by 7.41% to 2900000.0 in 2024, then fell by 29.76% to 3763000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Cash from Operations are 3763000.0 (Q4 2025), 4200000.0 (Q3 2025), and 3504000.0 (Q2 2025).